daiichi sankyo co ltd
(4568:Tokyo Stock Exchange)
Transactions by DAIICHI SANKYO CO LTD (4568) in the last 6 months
I'ROM HOLDINGS CO., LTD. (TSE:2372) agreed to acquire remaining 90.8% stake in DNAVEC Corporation from a group of shareholders for approximately ¥890 million on October 25, 2013. The shareholders include JAFCO Biotechnology No.1 Venture Capital Investment Limited Partnership, Kyowa Hakko Kirin Co., Ltd. (TSE:4151), Hisamitsu Pharmaceutical Co. Inc. (TSE:4530), JAFCO Co., Ltd. (TSE:8595), Daiichi Sankyo Company, Limited (TSE:4568), Astellas Pharma, Inc. (TSE:4503), The ...
Daiichi Sankyo Company, Limited
Hisamitsu Pharmaceutical Co. Inc.
JAFCO Biotechnology No.1 Venture Capital Investment Limited Partnership
JAFCO Co., Ltd.
Kyowa Hakko Kirin Co., Ltd.
Mitsubishi UFJ Capital Co. Ltd.
MUFG Venture Capital No.1 Limited Liability Partnership
The Kato Memorial Bioscience Foundation
Whiz Partners Inc.
OiDE Fund was launched on September 17, 2013 with a fund size of JPY 1 billion (USD $10.08 million). Mitsubishi UFJ Capital Co. Ltd. invested JPY 200 million (USD $2.01 million) to the fund. Limited partners includes Daiichi Sankyo Company, Limited which invested JPY 100 million (USD $1 million) and Organization for Small and Medium Enterprises and Regional Innovation, Japan which invested JPY 450 million (USD $4.53 million) to the fund.
Organization For Small & Medium Enterprises And Regional Innovation, Japan, Investment Arm
|Beiersdorf AG||€73.33 EUR||-0.86|
|BioCryst Pharmaceuticals Inc||$5.92 USD||+0.03|
|Cyclacel Pharmaceuticals Inc||$4.28 USD||-0.33|
|Eisai Co Ltd||¥4,045 JPY||+5.00|
|Ipsen SA||€33.96 EUR||-0.145|
|View Industry Companies|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26